BRIEF published on 04/30/2024 at 11:05, 2 years ago New Partnership Between BioMed X Institute and Merck Focuses on Immuno-Oncology Cancer Research BioMed X Institute Immunotherapy Merck Tumor Immunogenicity
PRESS RELEASE published on 04/30/2024 at 11:00, 2 years ago New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg Biomedical research institute, BioMed X, partners with Merck to develop novel immunotherapeutic strategies to enhance tumor immunogenicity for cancer patients Cancer Research Immunotherapy Merck Tumor Immunogenicity BioMed X
PRESS RELEASE published on 02/06/2024 at 16:00, 2 years 2 months ago New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine BioMed X Institute and Universitatsmedizin Mannheim researchers publish results of collaboration on new neoepitope vaccine in diffuse midline glioma in Science Advances BioMed X Institute Universitatsmedizin Mannheim Neoepitope Vaccine Diffuse Midline Glioma Science Advances
PRESS RELEASE published on 11/07/2023 at 12:00, 2 years 5 months ago BioMed X Launches a New Call for Application in Autoimmune Disease Research
PRESS RELEASE published on 10/31/2023 at 17:00, 2 years 6 months ago BioMed X and AbbVie Start New Research Project in the USA
PRESS RELEASE published on 06/29/2023 at 11:00, 2 years 10 months ago BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
PRESS RELEASE published on 04/27/2023 at 14:00, 3 years ago BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
PRESS RELEASE published on 04/04/2023 at 11:00, 3 years 1 month ago BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Published on 05/06/2026 at 02:17, 5 hours ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 5 hours 17 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 5 hours 17 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 5 hours 47 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 5 hours 57 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 07:00, 16 minutes ago Zalando delivers strong Q1 as artificial intelligence and ABOUT YOU integration drive growth and efficiencies
Published on 05/06/2026 at 07:00, 17 minutes ago Cancellation of remaining publicly held registered shares of u-blox Holding AG and delisting from the SIX Swiss Exchange as of 18 May 2026
Published on 05/06/2026 at 07:00, 17 minutes ago Klöckner & Co considerably increases its operating income in the first quarter of 2026 and continues on its strategic path to success
Published on 05/06/2026 at 07:00, 17 minutes ago Branicks Group AG: 2025 EPRA-Sustainability Report published
Published on 05/06/2026 at 07:00, 17 minutes ago TeamViewer Q1 2026: Revenue in line with expectations, Enterprise ARR up +8% cc, full-year 2026 guidance reaffirmed
Published on 05/05/2026 at 19:00, 12 hours 17 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 12 hours 17 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 12 hours 37 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 13 hours 14 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
